Myocarditis associated with immune checkpoint inhibitors: Practical considerations in diagnosis and management

Immune checkpoint inhibitors (ICI) have caused radical changes in the treatment scheme of many types of cancer in the past 10 years. ICIs are specific monoclonal antibodies that increase T-cell mediated immune response against cancer cells. Despite important advances in cancer treatment, uncontrolle...

Descripción completa

Detalles Bibliográficos
Autores principales: Gürdoğan, Muhammet, Yalta, Kenan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460679/
https://www.ncbi.nlm.nih.gov/pubmed/32749254
http://dx.doi.org/10.14744/AnatolJCardiol.2020.79584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460679/
https://www.ncbi.nlm.nih.gov/pubmed/32749254
http://dx.doi.org/10.14744/AnatolJCardiol.2020.79584

Ejemplares similares